894 related articles for article (PubMed ID: 37245024)
1. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
2. Protection against β-amyloid neurotoxicity by a non-toxic endogenous N-terminal β-amyloid fragment and its active hexapeptide core sequence.
Forest KH; Alfulaij N; Arora K; Taketa R; Sherrin T; Todorovic C; Lawrence JLM; Yoshikawa GT; Ng HL; Hruby VJ; Nichols RA
J Neurochem; 2018 Jan; 144(2):201-217. PubMed ID: 29164616
[TBL] [Abstract][Full Text] [Related]
3. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
[TBL] [Abstract][Full Text] [Related]
4. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
5. Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer's disease.
Ali T; Klein AN; McDonald K; Johansson L; Mukherjee PG; Hallbeck M; Doh-Ura K; Schatzl HM; Gilch S
J Neuroinflammation; 2023 Jul; 20(1):177. PubMed ID: 37507761
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
[TBL] [Abstract][Full Text] [Related]
7. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
Trojan E; Tylek K; Schröder N; Kahl I; Brandenburg LO; Mastromarino M; Leopoldo M; Basta-Kaim A; Lacivita E
Mol Neurobiol; 2021 Dec; 58(12):6203-6221. PubMed ID: 34468933
[TBL] [Abstract][Full Text] [Related]
8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
9. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
10. The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model.
Forest KH; Taketa R; Arora K; Todorovic C; Nichols RA
Front Mol Neurosci; 2021; 14():576038. PubMed ID: 33912008
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
[TBL] [Abstract][Full Text] [Related]
12. Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis.
Wang J; Liu B; Xu Y; Luan H; Wang C; Yang M; Zhao R; Song M; Liu J; Sun L; You J; Wang W; Sun F; Yan H
Exp Neurol; 2022 Jan; 347():113870. PubMed ID: 34563511
[TBL] [Abstract][Full Text] [Related]
13. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
16. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
17. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
19. Reduced mitochondria membrane potential and lysosomal acidification are associated with decreased oligomeric Aβ degradation induced by hyperglycemia: A study of mixed glia cultures.
Huang YC; Hsu SM; Shie FS; Shiao YJ; Chao LJ; Chen HW; Yao HH; Chien MA; Lin CC; Tsay HJ
PLoS One; 2022; 17(1):e0260966. PubMed ID: 35073330
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X
Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
